基础医学与临床
基礎醫學與臨床
기출의학여림상
Basic & Clinical Medicine
2015年
9期
1194-1198
,共5页
何艳%王丹丹%陈华妹%李勇杰%薛启祥%王旭东
何豔%王丹丹%陳華妹%李勇傑%薛啟祥%王旭東
하염%왕단단%진화매%리용걸%설계상%왕욱동
雌激素%细胞外信号调节激酶%局部黏着斑激酶%失巢凋亡%乳腺癌细胞
雌激素%細胞外信號調節激酶%跼部黏著斑激酶%失巢凋亡%乳腺癌細胞
자격소%세포외신호조절격매%국부점착반격매%실소조망%유선암세포
estrogen%extracellular signal-regulated kinase%focal adhesion kinase%anoikis%breast cancer cells
目的:探讨雌激素(E2)对MCF-7乳腺癌细胞抗失巢凋亡能力的影响及细胞外信号调节激酶(ERK)-局部黏着斑激酶( FAK)通路在其中的作用,以加深对E2促癌作用信号机制的认识。方法用MCF-7乳腺癌细胞,聚甲基丙烯酸羟乙基酯( poly-Hema)涂层培养细胞诱导失巢凋亡, E2刺激及MEK和FAK抑制剂预处理细胞。用蛋白印迹法检测ERK和FAK磷酸化,台盼蓝染色细胞计数法检测细胞存活力, Hoechst荧光染色法验证细胞凋亡。结果用Poly-Hema悬浮培养可显著降低细胞存活力( P<0.01), E2处理则可明显增强悬浮培养细胞的存活力( P<0.05),同时减少细胞凋亡;E2可引起ERK和FAK磷酸化,MEK抑制剂则可显著抑制E2诱导的ERK和FAK磷酸化,并使E2处理的悬浮培养细胞存活率下降57.48%( P<0.01);FAK抑制剂能明显抑制FAK和ERK的磷酸化,同时使E2处理的悬浮培养细胞存活率下降53.59%( P<0.01)。结论 E2可明显提高MCF-7乳腺癌细胞对抗失巢凋亡的能力,该细胞保护效应可能与E2激活胞内ERK-FAK信号活动有关。
目的:探討雌激素(E2)對MCF-7乳腺癌細胞抗失巢凋亡能力的影響及細胞外信號調節激酶(ERK)-跼部黏著斑激酶( FAK)通路在其中的作用,以加深對E2促癌作用信號機製的認識。方法用MCF-7乳腺癌細胞,聚甲基丙烯痠羥乙基酯( poly-Hema)塗層培養細胞誘導失巢凋亡, E2刺激及MEK和FAK抑製劑預處理細胞。用蛋白印跡法檢測ERK和FAK燐痠化,檯盼藍染色細胞計數法檢測細胞存活力, Hoechst熒光染色法驗證細胞凋亡。結果用Poly-Hema懸浮培養可顯著降低細胞存活力( P<0.01), E2處理則可明顯增彊懸浮培養細胞的存活力( P<0.05),同時減少細胞凋亡;E2可引起ERK和FAK燐痠化,MEK抑製劑則可顯著抑製E2誘導的ERK和FAK燐痠化,併使E2處理的懸浮培養細胞存活率下降57.48%( P<0.01);FAK抑製劑能明顯抑製FAK和ERK的燐痠化,同時使E2處理的懸浮培養細胞存活率下降53.59%( P<0.01)。結論 E2可明顯提高MCF-7乳腺癌細胞對抗失巢凋亡的能力,該細胞保護效應可能與E2激活胞內ERK-FAK信號活動有關。
목적:탐토자격소(E2)대MCF-7유선암세포항실소조망능력적영향급세포외신호조절격매(ERK)-국부점착반격매( FAK)통로재기중적작용,이가심대E2촉암작용신호궤제적인식。방법용MCF-7유선암세포,취갑기병희산간을기지( poly-Hema)도층배양세포유도실소조망, E2자격급MEK화FAK억제제예처리세포。용단백인적법검측ERK화FAK린산화,태반람염색세포계수법검측세포존활력, Hoechst형광염색법험증세포조망。결과용Poly-Hema현부배양가현저강저세포존활력( P<0.01), E2처리칙가명현증강현부배양세포적존활력( P<0.05),동시감소세포조망;E2가인기ERK화FAK린산화,MEK억제제칙가현저억제E2유도적ERK화FAK린산화,병사E2처리적현부배양세포존활솔하강57.48%( P<0.01);FAK억제제능명현억제FAK화ERK적린산화,동시사E2처리적현부배양세포존활솔하강53.59%( P<0.01)。결론 E2가명현제고MCF-7유선암세포대항실소조망적능력,해세포보호효응가능여E2격활포내ERK-FAK신호활동유관。
Objective To investigate the effects of estrogen ( E2) on the resistance to anoikis and a possible role of extracellular signal-regulated kinse ( ERK)-focal adhesion kinse ( FAK) signaling in the effect of estrogen to under-stand its underlying mechanism .Methods Poly-Hema-coated culture of human breast cancer cell line MCF-7 was used to induce anoikis .Cells were treated with E2 and/or pretreated with MEK or FAK inhibitors .Western blot was used to assess the phosphorylation of ERK and FAK , trypan blue staining and cell counting were employed to evaluate cell viability , and Hoechst staining was used to check apoptosis .Results Suspension culture greatly re-duced cell survival (P<0.01), and exposure of MCF-7 cells to E2 (10 nmol/L) led to a significantly increased resistance to anoikis and survival ( P<0.05 ) as compared to DMSO .Meanwhile , E2 induced increased phospho-rylation of both ERK and FAK .Pharmacological inhibition of MEK with U 0126 ( 10 μmol/L ) reduced E2-in-creased cell survival by 57.48%(P<0.01) and E2-decreased anoikis;Treatment with FAK inhibitor (10μmol/L) attenuated E2-enhanced cell survival by 53.59% ( P<0.01 ) and E2-reduced apoptosis .Conclusions E2 con-tributes to the enhanced cell viability and increased resistance to anoikis in MCF-7 breast cancer cells , and ERK-FAK signaling may be involved in the E 2-stimulated survival during suspension culture of MCF-7 cells.